AI assistant
ATLAS ARTERIA — Director's Dealing 2021
Mar 29, 2021
64368_rns_2021-03-29_5ca6a281-f779-463b-a892-966dfa8a8df5.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity Atlas Arteria (ALX)
ABN
Atlas Arteria Limited (ACN 141 075 201) (ATLAX) Atlas Arteria International Limited (EC43828) (ATLIX)
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | Graeme Bevans (Director of ATLAX) |
|---|---|
| Date of last notice | 2 July 2020 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Direct or indirect interest | Direct |
|---|---|
| Nature of indirect interest | N/A |
| (including registered holder) | |
| Note: Provide details of the circumstances giving rise to the relevant | |
| interest. | |
| Date of change | 24 March 2021 |
| No. of securities held prior to change | Fully Paid Ordinary ALX Stapled Securities |
| (Ordinary Stapled Securities): 153,730 | |
| Performance Rights granted under ALX’s | |
| Long Term Incentive Plan (Performance | |
| Rights): 303,853 | |
| Class | Ordinary Stapled Securities |
| Number acquired | 75,929 |
| Number disposed | Nil |
| Value/Consideration | See “Nature of Change” section below |
| Note: If consideration is non-cash, provide details and estimated | |
| valuation |
- See chapter 19 for defined terms.
01/01/2011
Appendix 3Y Page 1
Appendix 3Y Change of Director’s Interest Notice
| No. of securities held after change | Ordinary Stapled Securities: 229,659Performance Rights: 303,853 |
|---|---|
| Nature of changeExample: on-market trade, off-market trade, exercise of options, issueof securities under dividend reinvestment plan, participation in buy-back | The Ordinary Stapled Securities wereawarded to Mr Bevans to satisfy his shortterm incentive award for FY20. Thenumber of Ordinary Stapled Securities wasdetermined by dividing $429,000 (beingMr Bevans STI Award for FY20 asdetermined by the Board) by $5.65 beingthe VWAP of Ordinary Stapled Securitiestraded on the ASX over the 10 trading daysimmediately following the announcementof ALX’s FY20 results. |
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Detail of contract | N/A |
|---|---|
| Nature of interest | N/A |
| Name of registered holder(if issued securities) | N/A |
| Date of change | N/A |
| No. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract inrelation to which the interest has changed | N/A |
| Interest acquired | N/A |
| Interest disposed | N/A |
| Value/ConsiderationNote: If consideration is non-cash, provide detailsand an estimated valuation | N/A |
| Interest after change | N/A |
- See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Appendix 3Y Change of Director’s Interest Notice
Part 3 –[+] Closed period
| Part 3 –+Closed period | |
|---|---|
| Were the interests in the securities or contracts detailedabove traded during a+closed period where prior writtenclearance was required? | No |
| If so, was prior written clearance provided to allow thetrade to proceed during this period? | N/A |
| If prior written clearance was provided, on what date wasthis provided? | N/A |
- See chapter 19 for defined terms.
01/01/2011
Appendix 3Y Page 3